Kathryn T. Hall (born 1964 in Oxford) is a leader in placebo research, Assistant professor of medicine part-time and molecular biologist[1] who directs research or teaches at several institutions, including the following: She has published many papers and one book about the biological basis of the placebo effect.
In 2012 she joined the Fellowship in Integrative Medicine at Beth Israel Deaconess Medical Center (BIDMC) and then in 2014 got a MPH in Public Health from Harvard T. H. Chan School of Public Health.
[13] She asserts that, "The placebo effect is a real neurological response involving multiple parts of the brain.
[15] This led the researchers to the idea of using genetic screening to identify placebo responders which in turn could improve patient care.
[11] She has also written about genetic markers in papers co-authored with Irving Kirsch and Paul M Ridker.